AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8791036
Drug: Clomipramine 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine 150 mg/day
Trial: 2467447
Drug: Invasive laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Invasive laser therapy (He‐Ne laser irradiation)
Trial: 23072263
Drug: Memantine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine (15 mg/day for 5 days)
Trial: 9272336
Drug: Two-component acellular
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-component acellular vaccine
Trial: 26971081
Drug: Sertraline 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline 400 mg/day
Trial: 29542344
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg estradiol valerate daily plus 4 mg medroxyprogesterone acetate (MPA), days 19-30
Trial: 29542344
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg estradiol valerate daily plus 100 mg micronized progesterone (MP), days 19-30
Trial: 29198157
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg C. foetida extract daily
Trial: 25675856
Drug: High-fat soup
RxNorm normalized name: MALT SOUP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat soup preload (0.8 kcal/g; 55% calories from fat)
Trial: 23134193
Drug: Acamprosate (666
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acamprosate (666 mg, 3 times daily, total 1,998 mg/d)
Trial: 10220121
Drug: Reboxetine (8‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine (8‐10 mg/day)
Trial: 11030486
Drug: Paroxetine (20‐40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20‐40 mg/day)
Trial: 9352392
Drug: BAY 10‐6734
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 10‐6734 (80 mg)
Trial: 9352392
Drug: BAY 10‐6734
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 10‐6734 (300 mg)
Trial: 30035585
Drug: Brief strategic
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief strategic therapy (BST)
Trial: 18036454
Drug: Combined antiplatelet
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined antiplatelet therapy (aspirin plus clopidogrel)
Trial: 12702735
Drug: 250 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml of a 6.4 % carbohydrate beverage (GLU trial)
Trial: 10680106
Drug: Ringer's solution
RxNorm normalized name: Ringer's solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer's solution (Group R)
Trial: 10680106
Drug: 2.5% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% glucose solution (Group G)
Trial: 8708587
Drug: Pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatment (pravastatin)
Trial: 1660502
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran with additional fluid (600 mL)
Trial: 28515057
Drug: Early reconstruction
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early reconstruction plus exercise therapy
Trial: 27086041
Drug: Monthly oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly oral doses of 60,000 IU of cholecalciferol
Trial: 23121378
Drug: Aliskiren (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren (300 mg daily)
Trial: 21946392
Drug: Olmesartan (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan (40 mg daily)
Trial: 17721009
Drug: Lipophilic statins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipophilic statins (atorvastatin, fluvastatin, pitavastatin, simvastatin)
Trial: 7741168
Drug: Bacitracin zinc
RxNorm normalized name: Bacitracin Zinc
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bacitracin zinc (120,000 U, 10-day treatment)
Trial: 7741168
Drug: Bacitracin (120,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacitracin (120,000 U, 10-day treatment)
Trial: 26473191
Drug: Targeted anticancer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted anticancer agents in Phase III RCTs
Trial: 23337270
Drug: Ankle block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ankle block administered before inflation of tourniquet (Group B)
Trial: 21147163
Drug: Physostigmine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine infusion (cholinergic challenge)
Trial: 20939783
Drug: Randomized controlled
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized controlled trials (RCTs) involving orthopedic implants
Trial: 10688340
Drug: Low TENS
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low TENS treatment
Trial: 1558292
Drug: Alcohol (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.8 ml of 100% alcohol/kg body weight)
Trial: 6234558
Drug: Microgranules of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microgranules of dihydroergotamine (30 mg/24 hours)
Trial: 6234558
Drug: Dihydroergotamine solution
DrugBank: Dihydroergotamine (DB00320)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine solution (similar dose)
Trial: 20818855
Drug: Four cycles
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four cycles of ABVD followed by 30 Gy of radiation therapy (group 1)
Trial: 20818855
Drug: Four cycles
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four cycles of ABVD followed by 20 Gy of radiation therapy (group 2)
Trial: 20818855
Drug: Two cycles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two cycles of ABVD followed by 20 Gy of radiation therapy (group 4)
Trial: 16155169
Drug: Percutaneous ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Percutaneous ethanol injection without aspiration (group A)
Trial: 16155169
Drug: Percutaneous ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Percutaneous ethanol injection with aspiration (group B)
Trial: 14621286
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium phosphate solution (SP)
Trial: 10971240
Drug: Lansoprazole 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 7.5 mg
Trial: 23748485
Drug: Palonosetron 0.25
RxNorm normalized name: palonosetron 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 0.25 mg IV (PAD)
Trial: 23748485
Drug: Ondansetron 24
RxNorm normalized name: ondansetron 24 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 24 mg orally (OAD)
Trial: 12598499
Drug: Oral mixed
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mixed micellar K(1) 2 mg (compared to healthy infants)
Trial: 10080041
Drug: Nicodermal patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicodermal patch
Trial: 31740426
Drug: Intravenous N-acetylcysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous N-acetylcysteine (NAC) followed by oral ramipril for 12 weeks
Trial: 29908297
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg intravenous zoledronic acid (ZOL) every 3 months
Trial: 21950312
Drug: Spironolactone 25mg
RxNorm normalized name: SPIRONOLACTONE 25MG TAB
DrugBank: Spironolactone (DB00421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spironolactone 25mg daily for 4 weeks followed by randomization to treatment or placebo for 36 weeks
Trial: 20684019
Drug: KIDNET (narrative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KIDNET (narrative exposure therapy)
Trial: 18277346
Drug: Prulifloxacin 600
RxNorm normalized name: Orbifloxacin
DrugBank: Orbifloxacin (DB11443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prulifloxacin 600 mg daily for 5 days after abortion (Group A)
Trial: 18277346
Drug: Prulifloxacin 600
RxNorm normalized name: Orbifloxacin
DrugBank: Orbifloxacin (DB11443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prulifloxacin 600 mg daily for 3 days after abortion (Group B)
Trial: 18277346
Drug: Prulifloxacin 600
RxNorm normalized name: Orbifloxacin
DrugBank: Orbifloxacin (DB11443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prulifloxacin 600 mg daily one day before and 2 days after abortion (Group C)
Trial: 11954884
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg orally three times a day
Trial: 7670452
Drug: Carbohydrate drink
RxNorm normalized name: Ensure Pre-Surgery Clear Carbohydrate Drink (Strawberry)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate drink containing 1 g.kg‐1 of carbohydrate four times daily
Trial: 6770731
Drug: Methylprednisolone, 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone, 0.5 mg/kg of body weight, intravenously every 6 h for 72 h
Trial: 2015447
Drug: Day care
RxNorm normalized name: CVS Everyday Care Probiotic Vegetable Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Day care treatment
Trial: 15193686
Drug: Fasting glucose
RxNorm normalized name: FAST TAKE (GLUCOSE) METER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting glucose levels (measured in mg/dl)
Trial: 18568379
Drug: Standard educationally-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard educationally-based treatment group (n = 20)
Trial: 19595251
Drug: Combined Therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined Therapy Group (n = 22)
Trial: 19595251
Drug: CBP Group,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBP Group, Combined Therapy Group, Thymosin alpha(1) Group
Trial: 22559218
Drug: NG‐monomethyl‐L‐arginine (L‐NMMA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NG‐monomethyl‐L‐arginine (L‐NMMA)
Trial: 11382368
Drug: Supervised group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised group (directly observed isoniazid therapy twice weekly)
Trial: 11382368
Drug: Peer group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer group (daily self‐administered isoniazid with peer counseling and education)
Trial: 9233181
Drug: Daily log
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily log
Trial: 30977385
Drug: Atezolizumab 1200
RxNorm normalized name: atezolizumab 1200 MG in 20 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atezolizumab 1200 mg every 3 weeks with chemotherapy (capecitabine or gemcitabine/carboplatin)
Trial: 30977385
Drug: Placebo every
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo every 3 weeks with chemotherapy (capecitabine or gemcitabine/carboplatin)
Trial: 12816022
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care
Trial: 11230282
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C repletion with 117 mg/d for 1 month after 1 month of depletion
Trial: 9035281
Drug: Isotonic 0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic 0.9% NaCl solutions (IS, n = 111)
Trial: 3297375
Drug: Sublingual lorazepam
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual lorazepam combined with high-dose metoclopramide (3 mg/kg) infused twice 3 h apart without i.v. dexamethasone
Trial: 31680180
Drug: Indocyanine green
RxNorm normalized name: Indocyanine Green
DrugBank: Indocyanine green (DB16024)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indocyanine green (ICG) administered on Day 0-3
Trial: 31680180
Drug: Indocyanine green
RxNorm normalized name: Indocyanine Green
DrugBank: Indocyanine green (DB16024)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indocyanine green (ICG) administered on Day 4-7
Trial: 27571099
Drug: Oat bran
RxNorm normalized name: Oat bran
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oat bran (4.5, 13.6 or 27.3 g) mixed in water
Trial: 24014477
Drug: Analytic group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analytic group therapy
Trial: 21910945
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of broccoli sprouts and GRP powder
Trial: 19286192
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba extract EGb 761 (240 mg/day)
Trial: 11380294
Drug: EPO (NeoRecormon)
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO (NeoRecormon) and oral iron for 4 weeks prior to surgery
Trial: 11380294
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron only for 4 weeks prior to surgery
Trial: 9409274
Drug: High-fat meals
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat meals (70 g of either rapeseed oil, olive oil, sunflower oil, palm oil, or butter)
Trial: 8298714
Drug: Pentaglobin (PG)
RxNorm normalized name: PG
DrugBank: Pentaglobin (DB15865)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentaglobin (PG) 5 ml/kg/day
Trial: 3681277
Drug: Diphenhydramine 50
RxNorm normalized name: diphenhydrAMINE 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 50 mg (H-1 receptor antagonist)
Trial: 31647775
Drug: Transcranial photobiomodulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial photobiomodulation (t‐PBM) with near‐infrared light (NIR), self-administered daily for 20 minutes, 830 nm peak wavelength, average irradiance 30 mW/cm2, average fluence 36 J/cm2, total energy delivered per session 2.9 kJ.
Trial: 23347793
Drug: sham injection
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sham injection
Trial: 9678815
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg o.m., clarithromycin 500 mg b.d. and secnidazole 2 g on alternate days for 1 week
Trial: 31898517
Drug: Patient advice,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient advice, an insole, heavy-slow resistance training, and an ultrasound-guided corticosteroid injection
Trial: 25201055
Drug: Stimulant medication
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant medication prescription
Trial: 8566261
Drug: 50 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 micrograms transdermal E2 plus 5 mg medroxyprogesterone acetate (MPA) continuously
Trial: 8566261
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg conjugated equine estrogen plus 2.5 mg MPA continuously
Trial: 2107241
Drug: Pollinex-R hyposensitization
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pollinex-R hyposensitization injections
Trial: 394282
Drug: Ibuprofen (Brufen)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (Brufen)
Trial: 394282
Drug: Both Diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both Diclofenac and Ibuprofen
Trial: 28221862
Drug: Conventional high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional high-dose cytarabine (HDAC)
Trial: 24440809
Drug: Acupuncture point
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture point injection (group A)
Trial: 22686081
Drug: Shenfu Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu Injection (SFI) + routine therapy
Trial: 17761829
Drug: Imatinib 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib 600 mg/day
Trial: 17761829
Drug: Imatinib <600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib <600 mg/day
Trial: 17498108
Drug: Vardenafil 10
RxNorm normalized name: vardenafil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vardenafil 10 mg
Trial: 10372934
Drug: Bismuth subcitrate
RxNorm normalized name: BISMUTH SUBCITRATE
DrugBank: Bismuth subcitrate potassium (DB09275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bismuth subcitrate 120 mg four times daily + amoxycillin 500 mg three times daily + metronidazole 400 mg three times daily (group III, n = 22)
Trial: 9389849
Drug: metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoclopramide 10 mg i.v.
Trial: 8839658
Drug: tropisetron 5
RxNorm normalized name: tropisetron 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tropisetron 5 mg by slow i.v.i.
Trial: 8839658
Drug: tropisetron by
RxNorm normalized name: tropisetron
DrugBank: Tropisetron (DB11699)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tropisetron by slow i.v.i., followed by 10 mg metoclopramide i.v.
Trial: 26256137
Drug: Topical Matricaria
RxNorm normalized name: Matricaria chamomilla flowering top oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Matricaria chamomilla (Chamomile) oil, applied 3 times/day for 3 weeks
Trial: 15505446
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion at rates of 0.1, 0.3, 0.5, 0.7, or 0.9 microg . ml . min
Trial: 27647873
Drug: Eluxadoline 1000
RxNorm normalized name: ELUXADOLINE
DrugBank: Eluxadoline (DB09272)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Eluxadoline 1000 mg
Trial: 28167156
Drug: Eluxadoline 100
RxNorm normalized name: eluxadoline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eluxadoline 100 mg
Trial: 29071928
Drug: CANT-3.0 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CANT-3.0 g group
Trial: 23265344
Drug: n‐3 PUFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n‐3 PUFA (1 g/day)
Trial: 21211295
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir 1000 mg 3 times per day for 8 weeks
Trial: 21211295
Drug: 0.15% ganciclovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15% ganciclovir ophthalmic gel, 4 times per day, and 0.1% fluorometholone eye drops, 3 times per day (test group)
Trial: 21211295
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (same ophthalmic gel and eye drops without oral ganciclovir)
Trial: 10803938
Drug: Ceftazidime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime (2 g/8 h)
Trial: 8628614
Drug: Nebulized adrenaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized adrenaline (4 mg/4 mL)
Trial: 1320305
Drug: Anticholest (apple-pectin-guar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticholest (apple-pectin-guar soft-drink) at 1 cup (17 g) every second day
Trial: 3535565
Drug: Meptazinol 3
RxNorm normalized name: meptazinol
DrugBank: Meptazinol (DB13478)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meptazinol 3 mg kg‐1
Trial: 16468292
Drug: Oral antibiotics,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotics, oral contraceptives, and topicals control (2 patients)
Trial: 7903132
Drug: Diclofenac retard
RxNorm normalized name: diclofenac sodium Extended Release Oral Tablet [Lofensaid Retard]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac retard 100 mg + Roxatidine 150 mg
Trial: 7903132
Drug: Diclofenac retard
RxNorm normalized name: diclofenac sodium Extended Release Oral Tablet [Lofensaid Retard]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac retard 100 mg + Placebo
Trial: 19740126
Drug: Desloratadine 5
RxNorm normalized name: desloratadine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine 5 mg/day
Trial: 30008985
Drug: H1 antihistamines
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H1 antihistamines (both desloratadine and levocetirizine)
Trial: 24184313
Drug: 2.5mg once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5mg once-daily risedronate
Trial: 24184313
Drug: 75mg once-monthly
RxNorm normalized name: vibegron
DrugBank: Vibegron (DB14895)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 75mg once-monthly risedronate
Trial: 15918057
Drug: Perindopril (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (8 mg/day)
Trial: 12453126
Drug: Immediate loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate loading of four ITI implants with Octa abutments and a U-shaped Dolder gold bar after 2 days.
Trial: 12453126
Drug: Delayed loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed loading of four ITI implants with Octa abutments after 3-4 months.
Trial: 12453126
Drug: Immediate loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate loading of implants with a U-shaped bar.
Trial: 23160261
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide (CYP)
Trial: 19841835
Drug: Traditional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional physical therapy for the upper limb
Trial: 26869679
Drug: No drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drug (ND)